CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes

Techniques that enable longitudinal tracking of cell fate after myocardial delivery are imperative for optimizing the efficacy of cell‐based cardiac therapies. However, these approaches have been underutilized in preclinical models and clinical trials, and there is considerable demand for site‐speci...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Stem Cells Transl Med
Κύριοι συγγραφείς: Ostrominski, John W., Yada, Ravi Chandra, Sato, Noriko, Klein, Michael, Blinova, Ksenia, Patel, Dakshesh, Valadez, Racquel, Palisoc, Maryknoll, Pittaluga, Stefania, Peng, Kah‐Whye, San, Hong, Lin, Yongshun, Basuli, Falguni, Zhang, Xiang, Swenson, Rolf E., Haigney, Mark, Choyke, Peter L., Zou, Jizhong, Boehm, Manfred, Hong, So Gun, Dunbar, Cynthia E.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley & Sons, Inc. 2020
Θέματα:
Enabling Technologies for Cell‐based Clinical Translation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519772/
https://ncbi.nlm.nih.gov/pubmed/32700830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0019
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια